Dr. Sarah Ferguson
Inclusion Criteria:
1. Patient must have histologically confirmed adenocarcinoma (usual/classic/NOS),
squamous cell carcinoma, adenosquamous carcinoma (Including glassy cell)
2. Patient must be FIGO Stage IA2, IBI, IB2 (2018 staging) without evidence of
definitive parametrial, vaginal, nodal or distant metastases on exam or imaging.
Patients with tumor size less than or equal to 4 cm confirmed on MRI prior to
randomization are eligible.
3. Patient must have uterine size < 5 years from enrollment with the exception of
non-melanoma skin cancer.
8. Patients who are unable to withstand prolonged lithotomy or steep trendelenberg.
9. Patient compliance and geographic proximity that do not allow adequate follow-up.
10. Patients with poorly controlled HIV with CD4 counts
